Covered recipient · General Payments record
ALAN GADSON STRUTH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$6,766.64
- Reported across 375 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.47 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $181.04 | 10 |
| Amgen Inc. | $92.72 | 5 |
| GENZYME CORPORATION | $71.28 | 2 |
| PFIZER INC. | $58.77 | 3 |
| GlaxoSmithKline, LLC. | $58.60 | 3 |
| Novo Nordisk AS | $56.01 | 3 |
| Janssen Biotech, Inc. | $23.32 | 1 |
| Lilly USA, LLC | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.43 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174954 | CMS |
| ABBVIE INC. | $15.98 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174956 | CMS |
| ABBVIE INC. | $23.66 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174958 | CMS |
| ABBVIE INC. | $10.01 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174960 | CMS |
| ABBVIE INC. | $25.05 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174962 | CMS |
| ABBVIE INC. | $18.76 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174964 | CMS |
| ABBVIE INC. | $6.70 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174966 | CMS |
| ABBVIE INC. | $26.30 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174968 | CMS |
| ABBVIE INC. | $10.07 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174970 | CMS |
| ABBVIE INC. | $21.08 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106174972 | CMS |
| Amgen Inc. | $19.03 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117393264 | CMS |
| Amgen Inc. | $21.92 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111717947 | CMS |
| Amgen Inc. | $17.01 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111717941 | CMS |
| Amgen Inc. | $18.36 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111717943 | CMS |
| Amgen Inc. | $16.40 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111717945 | CMS |
| GENZYME CORPORATION | $35.91 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139583908 | CMS |
| GENZYME CORPORATION | $35.37 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139583934 | CMS |
| GlaxoSmithKline, LLC. | $14.73 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116465790 | CMS |
| GlaxoSmithKline, LLC. | $28.07 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116653083 | CMS |
| GlaxoSmithKline, LLC. | $15.80 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116510173 | CMS |
| Janssen Biotech, Inc. | $23.32 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078557953 | CMS |
| Lilly USA, LLC | $14.73 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136014048 | CMS |
| Novo Nordisk Inc | $17.25 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096796137 | CMS |
| Novo Nordisk Inc | $19.29 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097808999 | CMS |
| Novo Nordisk Inc | $19.47 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096609032 | CMS |
| PFIZER INC. | $17.38 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130898906 | CMS |
| PFIZER INC. | $18.32 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130898958 | CMS |
| PFIZER INC. | $23.07 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130898953 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.